Cardiopulmonary exercise testing as a novel endpoint in clinical trials on ATTR amyloid cardiomyopathy

17 May 2025 (16:10 - 16:20)
Organised by: Logo
Congress Presentation Part of: Late-breaking science in heart failure, cardiomyopathies, pulmonary hypertension and valvular heart disease Clinical HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)